Mayne Pharma Group Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	59.84	110.07	92.62	96.67	97.98
Short-Term Investments	40.56	39.21	127.53	-	-
Trading Asset Securities	-	-	-	1.33	-
Cash & Short-Term Investments	100.4	149.28	220.14	98.01	97.98
Cash Growth	-32.74%	-32.19%	124.62%	0.03%	-28.89%
Accounts Receivable	164.62	176.47	177.4	259.72	175.83
Other Receivables	17.28	31.21	32.12	23.3	17.51
Receivables	181.9	207.68	209.52	283.02	193.34
Inventory	50.56	74.63	82.7	108.91	102.51
Prepaid Expenses	16.37	19.2	13.1	11.57	8.85
Restricted Cash	2.37	2.32	9.1	0.41	0.37
Other Current Assets	1.19	7.49	19.08	9.71	13.48
Total Current Assets	352.79	460.59	553.63	511.62	416.53
Property, Plant & Equipment	58.87	53.33	51.48	225.86	221.6
Goodwill	-	-	-	22.13	59.54
Other Intangible Assets	542.11	567.86	615.23	396.32	1,068
Long-Term Deferred Tax Assets	41.76	45.34	22.66	118.49	172.21
Long-Term Deferred Charges	3.67	0.72	2.04	9.07	-491.28
Other Long-Term Assets	15.41	15.34	2.32	4.45	16.7
Total Assets	1,015	1,143	1,247	1,288	1,463
Accounts Payable	30.25	20.87	32.03	63.57	42.36
Accrued Expenses	140.41	179.85	195.87	113.19	63.78
Short-Term Debt	-	-	10.81	405.37	51.16
Current Portion of Long-Term Debt	35.15	31.64	-	-	1.08
Current Portion of Leases	3.46	3.82	3.62	2.63	2.89
Current Income Taxes Payable	-	-	-	1.22	-
Other Current Liabilities	51.73	109.39	68.64	43.33	61.26
Total Current Liabilities	261.01	345.58	310.96	629.31	222.53
Long-Term Debt	-	-	28.48	-	285.8
Long-Term Leases	2.66	3.36	4.6	5.67	6.97
Pension & Post-Retirement Benefits	0.46	0.33	0.3	0.28	0.65
Long-Term Deferred Tax Liabilities	8.8	7.35	7.8	6.03	13.46
Other Long-Term Liabilities	371.4	332.37	260.86	108.4	162.19
Total Liabilities	644.32	688.99	612.99	749.7	691.61
Common Stock	1,226	1,224	1,234	1,239	1,239
Retained Earnings	-1,041	-944	-769.77	-840.35	-559.06
Comprehensive Income & Other	185.29	173.97	170.44	147.7	88.88
Total Common Equity	370.28	454.19	634.36	545.88	768.36
Minority Interest	-	-	-	-7.65	3.22
Shareholders' Equity	370.28	454.19	634.36	538.23	771.58
Total Liabilities & Equity	1,015	1,143	1,247	1,288	1,463
Total Debt	41.27	38.82	47.51	413.67	347.9
Net Cash (Debt)	59.13	110.46	172.64	-315.66	-249.92
Net Cash Growth	-46.47%	-36.02%	-	-	-
Net Cash Per Share	0.75	1.39	2.10	-3.84	-3.18
Filing Date Shares Outstanding	81.25	81.25	83.42	88.24	88.24
Total Common Shares Outstanding	81.25	81.25	83.42	88.24	88.24
Working Capital	91.78	115.01	242.67	-117.69	194
Book Value Per Share	4.56	5.59	7.60	6.19	8.71
Tangible Book Value	-171.82	-113.67	19.14	127.44	-359.08
Tangible Book Value Per Share	-2.11	-1.40	0.23	1.44	-4.07
Land	2.98	2.98	2.98	8.1	9.17
Buildings	19.92	19.92	19.92	128.95	112.53
Machinery	63.69	60.62	65.59	184.83	166.88
Construction In Progress	14.04	6.63	-0.01	11.18	15.24

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.